{"title":"mh相关疾病:谁真的需要非触发技术?","authors":"Ronald S. Litman DO, FAAP","doi":"10.1053/j.sane.2007.06.007","DOIUrl":null,"url":null,"abstract":"<div><p><span>Malignant hyperthermia<span><span> (MH) is a pharmacogenetic clinical syndrome that occurs </span>in patients with preexisting abnormal </span></span>skeletal muscle<span><span>. It manifests clinically as a hypermetabolic crisis when a MH-susceptible individual is exposed to an inhalational anesthetic or a depolarizing </span>muscle relaxant (ie, succinylcholine).</span></p></div>","PeriodicalId":82686,"journal":{"name":"Seminars in anesthesia","volume":"26 3","pages":"Pages 113-119"},"PeriodicalIF":0.0000,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.sane.2007.06.007","citationCount":"3","resultStr":"{\"title\":\"MH-associated diseases: who really needs a non-triggering technique?\",\"authors\":\"Ronald S. Litman DO, FAAP\",\"doi\":\"10.1053/j.sane.2007.06.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Malignant hyperthermia<span><span> (MH) is a pharmacogenetic clinical syndrome that occurs </span>in patients with preexisting abnormal </span></span>skeletal muscle<span><span>. It manifests clinically as a hypermetabolic crisis when a MH-susceptible individual is exposed to an inhalational anesthetic or a depolarizing </span>muscle relaxant (ie, succinylcholine).</span></p></div>\",\"PeriodicalId\":82686,\"journal\":{\"name\":\"Seminars in anesthesia\",\"volume\":\"26 3\",\"pages\":\"Pages 113-119\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1053/j.sane.2007.06.007\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in anesthesia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0277032607000360\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in anesthesia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0277032607000360","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
MH-associated diseases: who really needs a non-triggering technique?
Malignant hyperthermia (MH) is a pharmacogenetic clinical syndrome that occurs in patients with preexisting abnormal skeletal muscle. It manifests clinically as a hypermetabolic crisis when a MH-susceptible individual is exposed to an inhalational anesthetic or a depolarizing muscle relaxant (ie, succinylcholine).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
